title: Why HIV virions have low numbers of envelope spikes: implications for vaccine development.
authors.affiliation: Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
authors.forename: John
authors.initials: J
authors.lastname: Schiller
authors.affiliation: Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States of America.
authors.forename: Bryce
authors.initials: B
authors.lastname: Chackerian
mesh_terms: D016915:AIDS Vaccines / Q000276:immunology*; D006678:HIV / Q000276:immunology* / Q000472:pathogenicity; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D014759:Viral Envelope Proteins / Q000276:immunology / Q000648:ultrastructure*; D014771:Virion / Q000276:immunology / Q000472:pathogenicity / Q000648:ultrastructure*
chemical_list: D016915:AIDS Vaccines; D014759:Viral Envelope Proteins
references.citation: Curr Opin HIV AIDS. 2014 May;9(3):224-34
references.pmid: 24714565
references.citation: J Immunol. 2002 Dec 1;169(11):6120-6
references.pmid: 12444114
references.citation: PLoS Pathog. 2010 May 27;6(5):e1000908
references.pmid: 20523901
references.citation: J Clin Invest. 2001 Aug;108(3):415-23
references.pmid: 11489935
references.citation: Nat Rev Immunol. 2006 Mar;6(3):231-43
references.pmid: 16498452
references.citation: Cell. 2014 Feb 13;156(4):633-48
references.pmid: 24529371
references.citation: Lancet Infect Dis. 2008 Sep;8(9):553-63
references.pmid: 18684670
references.citation: J Immunol. 2008 May 1;180(9):5816-25
references.pmid: 18424700
references.citation: Immunol Rev. 2010 Sep;237(1):249-63
references.pmid: 20727040
references.citation: Cancer Prev Res (Phila). 2013 Nov;6(11):1242-50
references.pmid: 24189371
references.citation: Vaccine. 1999 Apr 23;17(17):2162-5
references.pmid: 10367949
references.citation: Science. 2003 Sep 5;301(5638):1374-7
references.pmid: 12920303
references.citation: Immunol Today. 1996 Dec;17(12):553-8
references.pmid: 8991286
references.citation: Nat Rev Microbiol. 2012 Oct;10(10):681-92
references.pmid: 22961341
references.citation: Infect Agent Cancer. 2010 Oct 20;5:19
references.pmid: 20961432
references.citation: Nature. 2006 Jun 15;441(7095):847-52
references.pmid: 16728975
references.citation: J Virol. 2004 Jul;78(13):6775-85
references.pmid: 15194752
references.citation: Vaccine. 2013 Apr 3;31(14):1777-84
references.pmid: 23415932
references.citation: J Exp Med. 2013 Feb 11;210(2):241-56
references.pmid: 23359068
references.citation: Immunol Rev. 2013 Jul;254(1):225-44
references.pmid: 23772623